BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma today announced that it has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. The combination ...
TEL AVIV, Feb 20 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab will remain a single company for generic and branded drugs, and expects to see significant interest in its active ...
Teva CEO Richard Francis expressed confidence that the API business could grow more than its current 6% annual rate. The CEO also assured that future M&A activities would be approached thoughtfully ...
With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out potential sites for new drug ingredients plants. Eli Lilly is jockeying for a tax ...
VANCOUVER, BC / ACCESS Newswire / September 2, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:XPHYF)(FSE:4XT) is pleased to announce the receipt of the Semaglutide active ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback